86 related articles for article (PubMed ID: 21926539)
1. Validation of neurokinin a assays in the United States and Europe.
Mamikunian P; Ardill JE; O'Dorisio TM; Krutzik SR; Vinik AI; Go VL; Armstrong L; Mamikunian G; Woltering EA
Pancreas; 2011 Oct; 40(7):1000-5. PubMed ID: 21926539
[TBL] [Abstract][Full Text] [Related]
2. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasms.
Diebold AE; Boudreaux JP; Wang YZ; Anthony LB; Uhlhorn AP; Ryan P; Mamikunian P; Mamikunian G; Woltering EA
Surgery; 2012 Dec; 152(6):1172-6. PubMed ID: 23102678
[TBL] [Abstract][Full Text] [Related]
4. Plasma Neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine Tumors of the Small Bowel.
Woltering EA; Voros BA; Thiagarajan R; Beyer DT; Ramirez RA; Wang YZ; Mamikunian G; Boudreaux JP
Pancreas; 2018 Aug; 47(7):843-848. PubMed ID: 29939909
[TBL] [Abstract][Full Text] [Related]
5. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
[TBL] [Abstract][Full Text] [Related]
6. [Attending physician must consider uncertainty. Don't let yourself be cheated by the numbers!].
Kallner A
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2467-9. PubMed ID: 17002162
[No Abstract] [Full Text] [Related]
7. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.
Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S
J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941
[TBL] [Abstract][Full Text] [Related]
8. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
9. Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis.
Ardill JE; McCance DR; Stronge WV; Johnston BT
Ann Clin Biochem; 2016 Mar; 53(Pt 2):259-64. PubMed ID: 26038607
[TBL] [Abstract][Full Text] [Related]
10. Specimen-collection standards complete major revisions.
Ernst DJ; Szamosi DI
MLO Med Lab Obs; 2005 Feb; 37(2):26-9. PubMed ID: 15762350
[No Abstract] [Full Text] [Related]
11. Multicenter study of homocysteine measurement--performance characteristics of different methods, influence of standards on interlaboratory agreement of results.
Tripodi A; Chantarangkul V; Lombardi R; Lecchi A; Mannucci PM; Cattaneo M
Thromb Haemost; 2001 Feb; 85(2):291-5. PubMed ID: 11246550
[TBL] [Abstract][Full Text] [Related]
12. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.
Danson S; Ranson M; Denneny O; Cummings J; Ward TH
Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193
[TBL] [Abstract][Full Text] [Related]
13. Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report.
Sweep FC; Fritsche HA; Gion M; Klee GG; Schmitt M;
Int J Oncol; 2003 Dec; 23(6):1715-26. PubMed ID: 14612946
[TBL] [Abstract][Full Text] [Related]
14. Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP).
Stevens LA; Stoycheff N
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S77-82. PubMed ID: 18359411
[TBL] [Abstract][Full Text] [Related]
15. Normative values of substance P and neurokinin A in neonates.
Wong CM; Boyle EM; Stephen RI; Smith J; Stenson BJ; McIntosh N; Laing IA
Ann Clin Biochem; 2010 Jul; 47(Pt 4):331-5. PubMed ID: 20592332
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
17. [National external quality assessment and comparability of assays for tumor markers measurements].
Zhang JT; Zhang CB; Ma R; Zhao HJ; Wang J; Wang ZG; Chen WX
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):993-7. PubMed ID: 20646652
[TBL] [Abstract][Full Text] [Related]
18. Comparison of radioimmunoassay and chemiluminescent assay methods to estimate canine blood cortisol concentrations.
Russell NJ; Foster S; Clark P; Robertson ID; Lewis D; Irwin PJ
Aust Vet J; 2007 Dec; 85(12):487-94. PubMed ID: 18042154
[TBL] [Abstract][Full Text] [Related]
19. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
20. A system to monitor a portion of the total testing process in medical clinics and laboratories: feasibility of a split-specimen design.
Shahangian S; Krolak JM; Gaunt EE; Cohn RD
Arch Pathol Lab Med; 1998 Jun; 122(6):503-11. PubMed ID: 9625417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
